Exciting news! One of our portfolio companies, OpenDNA, has achieved yet another remarkable milestone, showcasing outstanding teamwork and delivering remarkable results. And that’s not all, we’re thrilled to announce that OpenDNA is now officially commercial in the US!
OpenDNA has created a cloud-based precision genomic medicine platform that predicts cardiovascular disease and diabetes risk and provides the personalized treatment. Data-driven medicine will improve patient outcomes and reduce healthcare costs!